Physician profile
Arlene T Wright
NPI 1598758567
$2,685.77
in general payments reported to CMS, 2019-2025
23 companies · $388 in 2025
The $388 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $176 · 2022: $493 · 2023: $1,082 · 2024: $547 · 2025: $388.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,017.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,016.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $326.87 | 2022-2023 | |
| Neurocrine Biosciences, INC. | $273.93 | 2023-2024 | Ingrezza |
| Novo Nordisk INC | $245.63 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $221.39 | 2022-2023 | |
| Sanofi-Aventis U.S. LLC | $142.71 | 2024-2025 | |
| Abiomed | $134.91 | 2023 | Impella |
| Paratek Pharmaceuticals, INC. | $125.00 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $125.00 | 2024 | Austedo Xr |
| Merck Sharp & Dohme LLC | $124.99 | 2023 | Verquvo |
| Tris Pharma INC | $121.66 | 2023 | Dyanavel Xr, Quillichew Er, Quillivant |
| Gilead Sciences, INC. | $118.50 | 2023 | |
| Pfizer INC. | $99.63 | 2025 | |
| Teleflex LLC | $91.90 | 2023 | Urolift |
| Amgen INC. | $91.72 | 2024 | Repatha |
| Medtronic, INC. | $91.56 | 2024 | Intellis Adaptivestim |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $89.29 | 2025 | Axonics |
| Neurelis, INC. | $63.44 | 2023 | Valtoco |
| Axonics, INC. | $63.33 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $44.26 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.51 | 2022 | |
| Lilly USA, LLC | $25.90 | 2025 | |
| Cranial Technologies, INC | $17.71 | 2025 | Doc Band |
| Glaxosmithkline, LLC. | $16.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arlene Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.